These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17005822)

  • 21. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.
    Kitchel B; Rasheed JK; Endimiani A; Hujer AM; Anderson KF; Bonomo RA; Patel JB
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4201-7. PubMed ID: 20660684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
    J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
    Crowley B; Benedí VJ; Doménech-Sánchez A
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3679-82. PubMed ID: 12384391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Contributes to the Minimum Inhibitory Concentration? Beyond β-Lactamase Gene Detection in Klebsiella pneumoniae.
    Maclean AKW; Morrow S; Niu F; Hanson ND
    J Infect Dis; 2024 Oct; 230(4):e777-e788. PubMed ID: 38654105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
    Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
    Endimiani A; Hujer AM; Perez F; Bethel CR; Hujer KM; Kroeger J; Oethinger M; Paterson DL; Adams MD; Jacobs MR; Diekema DJ; Hall GS; Jenkins SG; Rice LB; Tenover FC; Bonomo RA
    J Antimicrob Chemother; 2009 Mar; 63(3):427-37. PubMed ID: 19155227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Joshi P; Shrivastava R; Bhagwat S; Patel M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
    Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
    Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
    Chiu SK; Wu TL; Chuang YC; Lin JC; Fung CP; Lu PL; Wang JT; Wang LS; Siu LK; Yeh KM
    PLoS One; 2013; 8(7):e69428. PubMed ID: 23894478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
    Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.
    Yan J; Pu S; Jia X; Xu X; Yang S; Shi J; Sun S; Zhang L
    Ann Lab Med; 2017 Sep; 37(5):398-407. PubMed ID: 28643488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
    Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.